Background: Carbapenem-resistant Acinetobacter baumannii has emerged as an important cause of infection in burn patients. This study aimed to characterize the antimicrobial susceptibility pattern, determine the prevalence of oxacillinase and metallo-beta-lactamase (MBL) genes, and type the A. baumannii isolates obtained from burn patients. Methods: During a 1-year period, a total of 40 nonduplicated isolates of A. baumannii were obtained from burn patients who were hospitalized in the Taleghani Burn Hospital in Ahvaz, in the southwest of Iran. Testing for antimicrobial susceptibility was carried out by disk diffusion and Etest. To screen MBL production, a double disk synergy and MBL E-test were performed. The presence of bla OXA-23-like , bla OXA-24-like , bla OXA-51-like and bla OXA-58-like , bla VIM , bla IMP and bla SPM , and bla NDM was sought by polymerase chain reaction (PCR). Repetitive extragenic palindromic sequence-based PCR was carried out for determination of isolates clonality. Results: Overall, 92.5% of isolates were carbapenem-resistant. Polymyxin B, colistin, and ampicillin-sulbactam were the most effective agents in vitro, with a susceptibility rate of 100%, 97.5%, and 72.5%, respectively. According to the double disk synergy and E-test, 55.6% and 97.3% of isolates were MBL producers, respectively. Furthermore, 70% of isolates harbored bla OXA-23-like and 20% were positive for bla OXA-24-like. However, no encoding genes were detected for bla VIM , bla IMP and bla SPM , bla NDM , and bla OXA-58-like . Repetitive extragenic palindromic sequence-based PCR revealed that carbapenem-resistant isolates belonged to four clones, including A, B, C, and D; the predominant clones were B and C. Conclusion: The rate of carbapenem resistance was high, and it appeared that bla OXA-23-like and bla OXA-24-like contributed to the carbapenem resistance of A. baumannii isolates. This result suggests that the two predominant clones of A. baumannii were spread among burn patients. In order to prevent future dissemination of resistant isolates among burn patients, an effective infection control plan is necessary.
Introduction
In patients with burn injuries, infection is the most common cause of death. 1 This is due to the fact that burn patients are susceptible and have a high risk for infection. 2 Acinetobacter baumannii has become an important and troubling pathogen in hospitals worldwide, and nosocomial outbreaks have been reported due to multidrug-resistant strains, particularly in the intensive care units and burn units. 3e6 At patient burn sites, it is difficult to distinguish between colonization and infection with A. baumannii. In fact, this organism is one of the very important causes of infection in these patients, and is isolated with increasing frequency from burn patients. 7, 8 Furthermore, outbreaks of A. baumannii are common in burn units, and the affected patients show a reservoir for this organism. 9 Most typically, carbapenems are the drugs of choice for treatment of A. baumannii infections, but the increased clinical use of these drugs has led to the progress of resistant strains. 10 Carbapenem-resistant A. baumannii has become a problematic nosocomial pathogen globally. 11 In the case of A. baumannii, different mechanisms, including change of penicillin binding protein, loss of outer membrane protein, efflux pump, and carbapenem-hydrolyzing enzymes are involved in carbapenem resistance. 3 It should be noted that carbapenem-inactivating enzymes belonging to the Class D carbapenemase (OXA enzymes) are the main mechanism of resistance in A. baumannii worldwide. 12 However, metallobeta-lactamase (MBL) production is less common in this organism. 11 For effective control and prevention of A. baumannii in hospitals, molecular typing is necessary to determine genomic fingerprinting. 13 According to previous studies of repetitive extragenic palindromic sequence-based polymerase chain reaction (REP-PCR), in most cases, one or more epidemic clones of A. baumannii are circulating in the studied hospital or burn units. 8, 14, 15 In this study, we decided to investigate antimicrobial resistance pattern, the prevalence of oxacillinase and MBL, and typing of A. baumannii isolates from burn patients.
Methods

Bacterial collection and phenotypic tests
During the period from August 2011 to August 2012, a total of 40 nonrepetitive A. baumannii isolates (colonization or infection) were obtained from burned wound samples of 40 patients [31 (77.5%) female and 9 (22.5%) male] who were hospitalized with burn injuries in Taleghani Hospital in Ahvaz, in the southwest of Iran. Of the noted isolates, 18 were recovered from wounds, 18 were recovered from skin biopsy, and four isolates were recovered from blood samples. A. baumannii initially was identified and characterized by biochemical tests such as Triple Sugar Iron (TSI) agar medium and oxidase test, API 20 NE kit (version 6.0, bioMerieux, Marcy L Etoile, France), and growth in 42 C, to ensure that the isolates were A. baumannii. 16 Genomic DNA for PCR was extracted by proteinase K, and sodium dodecyl sulfate method as previously described. 17 Presumptive A. baumannii isolates were confirmed to the species level by PCR amplification for bla OXA-51-like . 18 
Antimicrobial susceptibility testing
Testing of susceptibility to antimicrobial agents was performed by disk diffusion in Mueller-Hinton agar and was interpreted according to guidelines of the Clinical Laboratory Standard Institute (CLSI 2011). 19 Bacterial suspension at a turbidity equivalent to a 0.5-McFarland standard was inoculated on a Mueller-Hinton agar plate (Merck, Frankfurt, Germany). The antimicrobial agents tested included: imipenem 10mg, meropenem 10mg, polymyxin B 300 units, gentamicin 10mg, ceftriaxone 30mg, colistin 10mg, piperacillin 100mg, piperacillin-tazobactam 100/10mg, cefepime 30mg, tobramycin 10mg, tigecycline 15mg, amikacin 30mg, tetracycline 30mg, ciprofloxacin 5mg, trimethoprimsulfamethoxazole 1.25/23.75mg, ceftazidime 30mg, rifampin 5mg, aztreonam 30mg, and ampicillin-sulbactam 10/10mg (MAST, Group Ltd., Merseyside, UK). 20 Reference strains, including Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used for quality control testing. 19 Minimum inhibitory concentrations (MICs) of imipenem, meropenem, colistin, and tigecycline were determined by the E-test strips (Liofilchem, Roseto degli Abruzzi, Italy) according to the manufacturer's instructions. The European Committee on Antimicrobial Susceptibility Testing criteria for the technical note on tigecycline in Acinetobacter spp. and other Gram-negative bacteria, was utilized for the tigecycline breakpoint. 21 
Phenotypic screening of MBL production
For the identification of MBL production, a double disk synergy (DDS) was performed. Briefly, bacterial suspension at a turbidity equivalent to 0.5 McFarland standards was inoculated on a Mueller-Hinton agar plate (Merck). Thereafter, two 10mg of imipenem disks were placed on the surface of an inoculated plate. A 0.5M EDTA solution was prepared and 10mL was added to one of the imipenem disks to obtain a desired concentration of 750mg. After overnight incubation, the inhibition zone of imipenem and imipenem plus EDTA disks were compared, and the enhancement in the inhibition zone of imipenem plus EDTA disk was considered as positive for MBL production. 22 ,23 E-test MBL strips (Liofilchem, Italy) were used to evaluate MBL production. The results were interpreted according to the manufacturer's instructions.
PCR amplification of OXA-type genes
A multiplex PCR analysis was performed to determine the presence of OXA-type carbapenemase, bla OXA-23-like , bla OXA-24-like and bla OXA-58-like . Amplification reaction was carried out in a final volume of 25mL with 1X PCR buffer, 1 U Taq polymerase, 2mM MgCl 2 , 200mM of Deoxynucleotide triphosphate (dNTP) (Sinaclon, Tehran, Iran), 0.2mM of each primer (TAG, Copenhagen A/S Denmark), and 1mL of template DNA. PCR conditions were programmed in a Mastercycler (Eppendorf, Hamburg, Germany) as follows: initial denaturation at 94 C for 5 minutes, followed by 30 cycles at 94 C for 30 seconds, 53 C for 40 seconds, and 72 C for 50 seconds, and a final extension at 72 C for 6 minutes. PCR products were separated with electrophoresis on 1.5% agarose gel (Sinaclon), and after staining with ethidium bromide, visualized under UV gel documentation system. A. baumannii reference strains, including NCTC 13304, NCTC 13302, and NCTC 13305 were used as positive control for bla OXA-23-like , bla OXA-24-like and bla OXA-58-like , respectively. A negative control was included in each PCR reaction, containing all components except the DNA template, which was replaced by distilled water. 24 For each gene, one amplicon was sequenced (Bioneer, Daejeon, South Korea).
Detection of MBL genes
To detect MBL genes, bla VIM and bla IMP were sought by PCR with specific primers that are listed in Table 1 , with a protocol used in two previous studies. 20, 25 Two clinical isolates of P. aeruginosa, harbor bla IMP and bla VIM, were sequenced by (Bioneer) and used as positive control for identification of these genes. DNA from a bla SPM positive P. aeruginosa was purchased from the Pasteur Institute of Iran and used as positive control for bla SPM in each PCR reaction. In addition , bla NDM was sought by PCR with standard conditions, but we do not have any positive control for this gene because the first report of New Delhi MBL-1 gene found in 2013 by Shahcheraghi et al 26 and our study was conducted from August 2011 to August 2012. Prior to 2012, the authors could not find any positive control for bla NDM in Iran.
REP-PCR
To determine clonal relatedness, REP-PCR was performed on all isolates with specific primers previously described, 27 that are listed in Table 1 . Amplification conditions were performed using previously established protocols with some modifications. 28 Each reaction mixture for PCR contained 1X PCR buffer, 3.5mM of MgCl 2 , 300mM of Deoxynucleotide triphosphate (dNTP), 3% Dimethyl sulfoxide (DMSO) (Sinaclon), 0.5mM of each primer (TAG Copenhagen A/S, Denmark), and 1 U of Taq polymerase and 1mL of genomic DNA in a final volume of 25mL. PCR conditions included: 94 C for 10 minutes; 30 cycles of 94 C for 1 minute, annealing temperatures 45 C for 1 minute, 72 o C for 2 minutes, and 72 C for 16 minutes. Amplification products were separated by electrophoresis on 1.2% agarose gel (Sinaclon); after staining with ethidium bromide, they were observed in a UV gel documentation system, then they were photographed and compared together by visual inspection. 28 All fingerprints were observed by one observer, and fingerprints were interpreted according to previous studies. 27 ,29
Statistical analysis
The results were analyzed using the IBM SPSS (Version.20 IBM, Chicago, IL, USA) version 16.0 to obtain frequencies and comparison among clones.
Results
Bacterial collection
Forty isolates of A. baumannii were studied, of which 20 (50%) were from the women's ward, 13 (32.5%) were from the intensive care unit, six (15%) were from the men's ward, and 
Antimicrobial susceptibility test
The results of antimicrobial susceptibility testing of the 40 isolates are shown in Table 2 . According to the findings, colistin and polymyxin B were the most effective antimicrobials in vitro against the majority of isolates of A. baumannii. Moreover, determination of MIC by the E-test showed that 92.5% of isolates were resistant to imipenem. The lowest level of MIC for imipenem was 0.38mg/mL, and the highest level was 256mg/mL. Most of the imipenem-resistant isolates (30%) had an imipenem MIC ¼ 256mg/mL. The meropenem MIC was similar to those for imipenem, and 92.5% of isolates were resistant to meropenem with the lowest value of MIC ¼ 0.19mg/mL, and the highest value was 32mg/mL. Most of the meropenem-resistant isolates (85%) had a meropenem MIC ¼ 32mg/mL. Furthermore, based on Etesting, 97.5% of isolates were susceptible to colistin and one isolate (2.5%) had MIC ¼ 3mg/mL. In the CLSI guideline, there is no breakpoint for colistin MIC ¼ 3mg/mL and we could not categorize this isolate as intermediate. No colistin-resistant isolates were detected. Tigecycline MIC showed that 55% of the isolates were sensitive, 10% intermediate, and 35% were resistant. The obvious difference was seen for imipenem MIC compared to the disk diffusion results. When the E-test was undertaken, 92.5% of isolates were resistant to imipenem, whereas imipenem disk identified 67.5% of isolates as resistant. For meropenem, the result of the E-test was consistent with the disk diffusion method and 92.5% of isolates were resistant by two methods.
Detection of OXA-type carbapenemase
PCR experiments with primers specific for bla OXA-23-like , bla OXA-24-like , and bla OXA-58-like were performed on all 40 isolates. Bla OXA-23-like was positive in 70% of isolates (28/40 isolates). Eight of the 40 isolates (20%) were bla OXA-24-like positive (Fig. 1) . No isolates were positive for bla OXA-58-like . Co-existence of bla OXA-23-like and bla OXA-24-like was not detected. Interestingly, one isolate was carbapenem-resistant, but only had bla OXA-51-like and was negative for bla OXA-23-like , bla OXA-24-like , and bla OXA-58-like . Additionally, carbapenem susceptible isolates were negative for bla OXA-23-like , bla OXA-24-like , and bla OXA-58-like .
MBL
To study the MBL production, carbapenem-resistant isolates were evaluated by DDS and E-test. The results obtained with DDS and the E-test indicated that 55.6% and 97.3% of carbapenem-resistant A. baumannii isolates produce MBL, respectively. No amplicon was obtained with primer targeting 
REP-PCR results
REP-PCR was carried out for evaluation of clonality of the isolates. Analysis of the REP-PCR results demonstrated that the isolates belonged to four genotypes (Fig. 2) . Among those genotypes, 12.5% (5 of 40 isolates) belonged to genotype A, 32.5% (13 of 40 isolates) belonged to genotype B, 32.5% (13 of 40 isolates) belonged to genotype C, and 22.5% (9 of 40 isolates) belonged to genotype D.
Nucleotide sequence accession number
The nucleotide sequences obtained in this study were submitted to the GenBank nucleotide sequence database under the accession numbers: HG937619 for bla OXA-23-like, HG937620 for bla OXA-24-like , and HG937621 for bla OXA-51-like .
Discussion
A. baumannii remains one of the most common nosocomial pathogens and frequent causes of outbreaks in burn wound infections. 2, 4, 23 Unfortunately, most of the isolates are resistant to antimicrobial agents. b-Lactamases are microbial enzymes that hydrolytically inactivate b-lactam antibiotics and these enzymes, due to the emergence of pathogenic bacteria resistant to b-Lactamases are microbial enzymes that hydrolytically inactivate b-lactam antibiotics and these enzymes can cause resistance to b-lactam antibiotics, including carbapenems, penicillins and cephalosporins. Based on Ambler classification, these enzymes are belonging to four molecular classes: A, B, C, and D. 30, 31 Class D serine carbapenemases belong to the OXA (oxacillinase) family, and are most prevalent in A. baumannii isolates. The ability of OXA enzymes to hydrolyze the isoxazolyl penicillin oxacillin is faster than classical penicillins (benzylpenicillin). 32 Provisionally, they can be grouped into six subclasses; however, today, based on amino acid sequence analysis, Class D carbapenemases are reclassified into 12 subgroups: OXA-23, OXA-24/40, OXA-48, OXA-51, OXA-58, OXA-134a, OXA-143, OXA-211, OXA-213, OXA-214, OXA-229, and OXA-235. In addition, they include 232 enzymes with few variants and the same carbapenemase activity. 31, 33 In burn patients, the resistance rate of A. baumannii against carbapenems has been reported from 33.33% to 98%. 15, 23, 34, 35 In our study, according to susceptibility test results, a considerable proportion of A. baumannii isolates (92.5%) were resistant to carbapenems, and this finding suggests that carbapenems are not appropriate for the treatment of A. baumannii infections in burn patients hospitalized at Taleghani hospital. In the present study, there was a difference between imipenem E-test results and imipenem disk diffusion. This indicated that imipenem disk could not detect 25% of resistant isolates and use of this disk for antimicrobial susceptibility could lead to false susceptible results. In contrast to imipenem, meropenem disk was the same as using the E-test, and detected all resistant isolates. It seems that meropenem disk is more appropriate than imipenem disk for identification of resistant isolates. Among the tested antibiotics, colistin and polymyxin B were the most effective agents in vitro, and 97.5% and 100% of isolates were susceptible, respectively. While colistin-resistant isolates have been reported worldwide, 36 no colistin-resistant isolates were obtained from burn patients. Ampicillin-sulbactam is another treatment option, and 72.5% of the isolates were susceptible to this drug in vitro. It has been proposed that ampicillinsulbactam is an effective and inexpensive treatment for nosocomial infection due to ampicillin-sulbactam susceptible A. baumannii. 37 However, it has been suggested that OXA carbapenemase plays an important role in carbapenem resistance in A. baumannii.
15
Outbreaks of carbapenem-resistant A. baumannii carrying bla OXA-23-like were discovered in different countries, 38e41 and the range of bla OXA-23-like has been reported from 31% to 100% worldwide. 11,13,40,42e46 In our study, the vast majority of isolates (70%) were positive for bla OXA-23-like . Moreover, we found that 20% of isolates harbor bla OXA-24-like , and this rate is inconsistent with previous studies globally, which reported the rate of bla OXA-24-like from 0% to 85.43%. 11,42,45e48 While several studies demonstrated the bla OXA-58-like gene in A. baumannii, it has been detected from 2% to 84.92% in different parts of the world, 13,42e44,46,48 In contrast, however, in our study, no isolate was positive for the bla OXA-58-like gene. Based on the DDS and E-test results, 55.6% and 97.3% of isolates were MBL producers. In spite of phenotypic test, no amplicon was detected for studied MBL genes. While MBL genes, bla IMP , bla VIM , bla NDM , and bla SPM have been reported sporadically in A. baumannii, 49e53 we could not detect any of these genes among our isolates. Similar to our results, different studies have been reported that A. baumannii isolates were MBL producers by phenotypic tests, but no MBL encoding genes were detected. 13,45,47,54e56 One probable reason for these positive MBLs may be due to the bactericidal activity of EDTA, which may lead to an increased inhibition zone, but this increase is false positive and not associated with true MBL production. 57 By contrast, these results may be true positive associated with another MBL gene. Other studies have indicated that false-negative results often occurred, in particular when a low level of resistance is observed and phenotypic detection tests are time-consuming. 58 Furthermore, one isolate of A. baumannii was carbapenem -resistant, but it had only the bla OXA-51-like gene, and other genes were not detected. The mechanism of carbapenem-resistance in this isolate may be in relation to the modification of penicillin binding proteins, loss of porins and decreased permeability, AmpC stable derepression, overexpression of efflux pump, or insertion of ISAba1 in upstream of bla OXA-51-like . 14,59e61 In addition, further research is needed to identify different carbapenem-resistant mechanisms in this isolate. Since we found only bla OXA-23-like and bla OXA-24-like , we therefore suppose that carbapenem resistance in our isolates is mostly due to these genes. REP-PCR is a useful tool for typing of A. baumannii and provides information about the epidemiology of this bacterium in the hospitals. In order to investigate the clonality of A. baumannii in different wards, REP-PCR was done and analysis of REP-PCR revealed that four clones (A, B, C, and D) are circulating in different wards. Consistent with our study, in a study on burn isolates of A. baumannii, Mahdian et al 62 reported that 11 clones were detected, of which four occurred most frequently. In the present study, Clones B and C were the most epidemic ones and it seems these clones were possibly interward spread and caused infection in burn patients.
In conclusion, we observed that the rate of carbapenemresistant A. baumannii was high among burn patients. In addition, the most effective drugs against A. baumannii in vitro were colistin and polymyxin B. Since resistant isolates only had bla OXA-23-like and bla OXA-24-like , it seems that carbapenem resistance in our isolates is more associated with these genes. Based on the information obtained from REP-PCR, two clones are more prevalent among burn patients. Information about clonality and type of resistance is useful in epidemiology of A. baumannii and further research is needed on burn patients with more isolates. We conclude that infection control policies and programs will be considered in order to control the dissemination of A. baumannii in burn units. Monitoring and management of A. baumannii can lead to control transmission of this organism in burn units.
Limitations
In this study, the results had certain limitations. The major limitations were the absence of a positive control for the NDM gene, the short period of our study, sample size, single center, and inadequate demographic data about patients from the different wards. Additionally, MIC for polymyxin B was not done.
